Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
University of Heidelberg Medical Center
University of Heidelberg Medical Center
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Shenzhen University General Hospital
University Hospital Muenster
Sunnybrook Health Sciences Centre
Swiss Pediatric Oncology Group
City of Hope Medical Center
Fudan University
University of North Carolina, Chapel Hill